Five patients presented to the Kenner Dermatology Clinic with granuloma formation after cosmetic augmentation with poly-L-lactic acid (Sculptra). One patient had injections to the dorsum of the hands, and 4 patients had infraorbital skin augmentation. None were immunocompromised.
Methods:
Literature review and multiple case report.
Results:
Three patients required surgical excision. One responded to saline dilution therapy, and one is awaiting surgical removal.
Conclusion:
Although temporary fillers are more costly, permanent fillers can result in granuloma formation over time. If the granulomas do not respond to saline dilution or Kenalog treatment, surgical excision will become necessary.
BeljaardsRCde RoosK-PBruinsFG. NewFill for skin augmentation: A new filler or failure?Dermatol Surg.2005;31:772–776.
3.
HumbleGMestD. Soft tissue augmentation using Sculptra. Facial Plast Surg.2004;20(2):157–163.
4.
EnglehardPHumbleGMestD. Safety of Sculptra: A review of clinical trial data. J Cosmet Laser Ther.2005;7:201–205.
5.
LoweNJ. Dispelling the myth: Appropriate use of poly-L-lactic acid and clinical considerations. J Eur Acad Dermatol Venereol. 2006;20(suppl 1):2–6.
6.
SaylanZ. Complications of long-lasting facial fillers. Am J Cosmet Surg.2006;23(3):127–132.
7.
VleggaarD. Poly-L-lactic acid: Consultation on the injection techniques. J Eur Acad Dermatol Venereol. 2006;20(suppl 1):17–21.
8.
SCULPTRA™ – P030050.U.S Food and Drug Administration. Center for Devices and Radiological Health. Part 2: Summary of Safety and Effectiveness. Available at: http://www.fda.gov/cdrh/PDF3/P030050.html. Accessed June 17, 2007.
9.
ValantinMAAubron-OlivierCGhosnJ. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. AIDS. 2003;17:2471–2477.
